Showing results (231-240 of 344) with videos related to
Sort By:
Pageof 35
Chemotherapy|May 1, 1995
Transferable amikacin resistance in gram-negative bacterial isolatesJ Kallová, T Macicková, A Majtánová, et al.International Journal of Legal Medicine|September 13, 2014
Impact height and wall distance in bloodstain pattern analysis--what patterns of round bloodstains can tell usM Kettner, A Schmidt, M Windgassen, et al.Fortschritte Der Neurologie-Psychiatrie|March 19, 2013
[First occurrence of an organic manic schizophreniform syndrome followed by catatonia induced by anti-NMDA-receptor encephalitis]M Fousse, C Becker, K Faßbender, et al.AJNR. American Journal of Neuroradiology|February 4, 2012
A comparison of 2 stroke devices: the new Aperio clot-removal device and the solitaire AB/FRC Roth, D Junk, P Papanagiotou, et al.The European Journal of Neuroscience|August 26, 2006
A deficiency in RFX3 causes hydrocephalus associated with abnormal differentiation of ependymal cellsD Baas, A Meiniel, C Benadiba, et al.Journal of Molecular Biology|September 15, 2000
Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoterG Caretti, F Cocchiarella, C Sidoli, et al.Molecular and Cellular Biology|April 25, 2000
A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-YJ Villard, M Peretti, K Masternak, et al.Der Radiologe|May 29, 2008
[Treatment of arteriosclerotic diseases of the carotid artery. The carotid stent]I Q Grunwald, P Papanagiotou, C Roth, et al.Tissue Antigens|June 11, 2013
Role of major histocompatibility complex class II expression by non-hematopoietic cells in autoimmune and inflammatory disorders: facts and fictionF V Duraes, C Thelemann, K Sarter, et al.Pageof 35